{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:13:36Z","timestamp":1783376016597,"version":"3.54.6"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.eprac.2025.08.006","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T01:01:31Z","timestamp":1755651691000},"page":"1554-1559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness and Safety of Early Insulin Glargine U100 and Glargine U300 Administration in the Management of Diabetic Ketoacidosis in Adults With Type 1 Diabetes Mellitus: A Randomized Clinical Trial"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2176-7182","authenticated-orcid":false,"given":"Amr Y.","family":"El Feky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa S.","family":"Abdou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Naguib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar F.","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa M.","family":"Elrahmany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eprac.2025.08.006_bib1","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dc19-2449","article-title":"Trends in emergency department visits and inpatient admissions for hyperglycemic crises in adults with diabetes in the U.S., 2006-2015","volume":"43","author":"Benoit","year":"2020","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.eprac.2025.08.006_bib2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.15585\/mmwr.mm6712a3","article-title":"Trends in diabetic ketoacidosis hospitalizations and In-Hospital mortality - united States, 2000-2014","volume":"67","author":"Benoit","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.eprac.2025.08.006_bib3","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2337\/dc17-1583","article-title":"Trends in hospital admission for diabetic ketoacidosis in adults with type 1 and type 2 diabetes in England, 1998-2013: a retrospective cohort study","volume":"41","author":"Zhong","year":"2018","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2025.08.006_bib4","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.2337\/dc22-1673","article-title":"Rates of hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011-2020","volume":"46","author":"McCoy","year":"2023","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.eprac.2025.08.006_bib5","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2337\/dc06-9909","article-title":"Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American Diabetes Association","volume":"29","author":"Wolfsdorf","year":"2006","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2025.08.006_bib6","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/dci24-0032","article-title":"Hyperglycemic crises in adults with diabetes: a consensus report","volume":"47","author":"Umpierrez","year":"2024","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2025.08.006_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14788","article-title":"The management of diabetic ketoacidosis in adults-An updated guideline from the Joint British Diabetes society for inpatient care","volume":"39","author":"Dhatariya","year":"2022","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.eprac.2025.08.006_bib8","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/pedi.12462","article-title":"Glargine co-administration with intravenous insulin in pediatric diabetic ketoacidosis is safe and facilitates transition to a subcutaneous regimen","volume":"18","author":"Harrison","year":"2017","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"10.1016\/j.eprac.2025.08.006_bib9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/dom.15007","article-title":"Comparative clinical efficacy and safety of insulin glargine 300 U\/ml (Toujeo) versus insulin glargine 100 U\/ml in type 2 diabetes and type 1 diabetes: a systematic literature review and meta-analysis","volume":"25","author":"Joshi","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.eprac.2025.08.006_bib10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes","volume":"32","author":"Kitabchi","year":"2009","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eprac.2025.08.006_bib11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/dom.14929","article-title":"Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: a randomized controlled trial","volume":"25","author":"Thammakosol","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"10.1016\/j.eprac.2025.08.006_bib12","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.2337\/dc21-0689","article-title":"Rising rates and widening socioeconomic disparities in diabetic ketoacidosis in type 1 diabetes in Scotland: a nationwide retrospective cohort observational study","volume":"44","author":"O'Reilly","year":"2021","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2025.08.006_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.12782","article-title":"Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes","volume":"19","author":"Heise","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.08.006_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4239\/wjd.v11.i4.100","article-title":"Glargine-300: an updated literature review on randomized controlled trials and real-world studies","volume":"11","author":"Ghosh","year":"2020","journal-title":"World J Diabetes"},{"issue":"1","key":"10.1016\/j.eprac.2025.08.006_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41572-020-0165-1","article-title":"Diabetic ketoacidosis","volume":"6","author":"Dhatariya","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.eprac.2025.08.006_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/acem.12673","article-title":"Prospective randomized trial of insulin glargine in acute management of diabetic ketoacidosis in the emergency department: a pilot study","volume":"22","author":"Doshi","year":"2015","journal-title":"Acad Emerg Med"},{"issue":"5","key":"10.1016\/j.eprac.2025.08.006_bib17","article-title":"Effectiveness of insulin glargine on recovery of patients with diabetic ketoacidosis: a randomized controlled trial","volume":"9","author":"Houshyar","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"8","key":"10.1016\/j.eprac.2025.08.006_bib18","doi-asserted-by":"crossref","DOI":"10.2174\/1573399817666210303095633","article-title":"Evaluation of early administration of insulin glargine in the acute management of diabetic ketoacidosis","volume":"17","author":"Mohamed","year":"2021","journal-title":"Curr Diabetes Rev"},{"issue":"5","key":"10.1016\/j.eprac.2025.08.006_bib19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1210\/js.2018-00400","article-title":"A retrospective study of early vs delayed home dose basal insulin in the acute management of diabetic ketoacidosis","volume":"3","author":"Rappaport","year":"2019","journal-title":"J Endocr Soc"},{"issue":"3","key":"10.1016\/j.eprac.2025.08.006_bib20","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3803\/EnM.2021.1341","article-title":"Effect of the concomitant use of subcutaneous basal insulin and intravenous insulin infusion in the treatment of severe hyperglycemic patients","volume":"37","author":"Lim","year":"2022","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"9","key":"10.1016\/j.eprac.2025.08.006_bib21","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2012-1244","article-title":"Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia","volume":"97","author":"Hsia","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.08.006_bib22","article-title":"Diabetic ketoacidosis updates: titratable insulin infusions and long-acting insulin early","volume":"2021","author":"Kinney","year":"2021","journal-title":"Crit Care Res Pract"},{"key":"10.1016\/j.eprac.2025.08.006_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2147\/DMSO.S351155","article-title":"Effects of ultra-long-acting insulin compared to long-acting insulin on diabetic ketoacidosis incidence in type 1 diabetes mellitus patients","volume":"15","author":"Alsofiani","year":"2022","journal-title":"Diabetes Metab Syndr Obes"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25010018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25010018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:38:03Z","timestamp":1765967883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25010018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1530891X25010018"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.08.006","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and Safety of Early Insulin Glargine U100 and Glargine U300 Administration in the Management of Diabetic Ketoacidosis in Adults With Type 1 Diabetes Mellitus: A Randomized Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}